Falkai, Peter

Innate immune cells and C-Reactive protein in acute First-Episode psychosis and schizophrenia: relationship to psychopathology and treatment

Steiner, J., Frodl, T., Schiltz, K., Dobrowolny, H., Jacobs, R., Fernandes, B. S., Guest, P. C., Meyer-Lotz, G., Borucki, K., Bahn, S., et al. (2019) · Schizophrenia Bulletin

Tryptophan and brain disordersSchizophrenia research and treatment

Cited by 123

Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality

Falkai, P., Schneider-Axmann, T., & Honer, W. G. (2000) · Biological Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 122

Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression

Schulze-Rauschenbach, S. C., Harms, U., Schlaepfer, T. E., Maier, W., Falkai, P., & Wagner, M. (2005) · British Journal of Psychiatry

Electroconvulsive Therapy StudiesTranscranial Magnetic Stimulation Studies

Cited by 122

pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium

Monoranu, C. M., Apfelbacher, M., Grünblatt, E., Puppe, B., Alafuzoff, I., Ferrer, I., Al‐Saraj, S., Keyvani, K., Schmitt, A., Falkai, P., et al. (2009) · Neuropathology and Applied Neurobiology

Autopsy Techniques and OutcomesMolecular Biology Techniques and Applications

Cited by 121

The effects of physical exercise in schizophrenia and affective disorders.

Malchow, B., Reich-Erkelenz, D., Oertel-Knöchel, V., Keller, K., Hasan, A., Schmitt, A., Scheewe, T. W., Cahn, W., Kahn, R. S., & Falkai, P. (2013) · European Archives of Psychiatry and Clinical Neuroscience

Schizophrenia research and treatmentPhysical Activity and Health

Cited by 111

Cholesterol synthesis rate in human hippocampus declines with aging

Thelen, K. M., Falkai, P., Bayer, T. A., & Lütjohann, D. (2006) · Neuroscience Letters

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 107

Anti‐amyloid antibody treatments for Alzheimer's disease

Perneczky, R., Dom, G., Chan, A., Falkai, P., & Bassetti, C. (2024) · European Journal of Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 106

HDAC1 links early life stress to schizophrenia-like phenotypes

Bahari-Javan, S., Varbanov, H., Halder, R., Benito, E., Kaurani, L., Burkhardt, S., Anderson-Schmidt, H., Anghelescu, I., Budde, M., Stilling, R. M., et al. (2017) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentHistone Deacetylase Inhibitors Research

Cited by 101

Effects of social exclusion on emotions and oxytocin and cortisol levels in patients with chronic depression

Jobst, A., Sabass, L., Palagyi, A., Bauriedl-Schmidt, C., Mauer, M. C., Sarubin, N., Buchheim, A., Renneberg, B., Falkai, P., Zill, P., et al. (2015) · Journal of Psychiatric Research

Neuroendocrine regulation and behaviorDeath Anxiety and Social Exclusion

Cited by 94

S3-Leitlinie Schizophrenie

Gäebel, W., Hasan, A., & Falkai, P. (2019) · Springer eBooks

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 91

Correlation between amygdala volume and age in bipolar disorder — A systematic review and meta-analysis of structural MRI studies

Usher, J., Leucht, S., Falkai, P., & Scherk, H. (2010) · Psychiatry Research: Neuroimaging

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 90

Lower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations

Jobst, A., Padberg, F., Mauer, M.-C., Daltrozzo, T., Bauriedl-Schmidt, C., Sabass, L., Sarubin, N., Falkai, P., Renneberg, B., Zill, P., et al. (2016) · Frontiers in Human Neuroscience

Neuroendocrine regulation and behaviorPersonality Disorders and Psychopathology

Cited by 88

Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer’s disease

Pajonk, F.-G., Kessler, H., Supprian, T., Hamzei, P., Bach, D., Schweickhardt, J., Herrmann, W., Obeid, R., Simons, A., Falkai, P., et al. (2005) · Journal of Alzheimer's Disease

Trace Elements in HealthDementia and Cognitive Impairment Research

Cited by 83

Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study

Hasan, A., Wolff-Menzler, C., Pfeiffer, S., Falkai, P., Weidinger, E., Jobst, A., Hoell, I., Malchow, B., Yeganeh-Doost, P., Strube, W., et al. (2015) · European Archives of Psychiatry and Clinical Neuroscience

Vagus Nerve Stimulation ResearchSchizophrenia research and treatment

Cited by 80

The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls-A randomized placebo-controlled, double-blind fMRI study

Guse, B., Falkai, P., Gruber, O., Whalley, H., Gibson, L., Hasan, A., Obst, K., Dechent, P., McIntosh, A., Suchan, B., et al. (2013) · Behavioural Brain Research

Transcranial Magnetic Stimulation StudiesSchizophrenia research and treatment

Cited by 75

The effect of aerobic exercise on cortical architecture in patients with chronic schizophrenia: a randomized controlled MRI study

Falkai, P., Malchow, B., Wobrock, T., Gruber, O., Schmitt, A., Honer, W. G., Pajonk, F.-G., Sun, F., & Cannon, T. D. (2013) · European Archives of Psychiatry and Clinical Neuroscience

Schizophrenia research and treatmentPhysical Activity and Health

Cited by 68

Antisaccade performance in patients with obsessive–compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype

Lennertz, L., Rampacher, F., Vogeley, A., Schulze-Rauschenbach, S., Pukrop, R., Ruhrmann, S., Klosterkötter, J., Maier, W., Falkai, P., & Wagner, M. (2012) · European Archives of Psychiatry and Clinical Neuroscience

Obsessive-Compulsive Spectrum DisordersNeural and Behavioral Psychology Studies

Cited by 62

Compensatory hyperactivations as markers of latent working memory dysfunctions in patients with obsessive–compulsive disorder: an fMRI study

Henseler, I., Gruber, O., Kraft, S., Krick, C., Reith, W., & Falkai, P. (2008) · Journal of Psychiatry and Neuroscience

Obsessive-Compulsive Spectrum DisordersNeural and Behavioral Psychology Studies

Cited by 61

Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial

Kessler, H., Pajonk, F.-G., Bach, D., Schneider-Axmann, T., Falkai, P., Herrmann, W., Multhaup, G., Wiltfang, J., Schäfer, S., Wirths, O., et al. (2008) · Journal of Neural Transmission

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 61

Characterization of SLITRK1 variation in obsessive-compulsive disorder

Ozomaro, U., Cai, G., Kajiwara, Y., Yoon, S., Makarov, V., Delorme, R., Betancur, C., Ruhrmann, S., Falkai, P., Grabe, H. J., et al. (2013) · PLoS ONE

Obsessive-Compulsive Spectrum DisordersGenetics and Neurodevelopmental Disorders

Cited by 52

Alexithymia in obsessive–compulsive disorder — Results from a family study

Grabe, H. J., Ruhrmann, S., Ettelt, S., Müller, A., Buhtz, F., Hochrein, A., Schulze-Rauschenbach, S., Meyer, K., Kraft, S., Reck, C., et al. (2006) · Psychotherapy and Psychosomatics

Psychosomatic Disorders and Their TreatmentsObsessive-Compulsive Spectrum Disorders

Cited by 49

Depression in Somatic Disorders: Is There a Beneficial Effect of Exercise?

Roeh, A., Kirchner, S. K., Malchow, B., Maurus, I., Schmitt, A., Falkai, P., & Hasan, A. (2019) · Frontiers in Psychiatry

Physical Activity and HealthCancer survivorship and care

Cited by 40

Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland

Adorjan, K., Pogarell, O., Pröbstl, L., Rüb, M., Wiegand, H. F., Tüscher, O., Lieb, K., Wassiliwizky, M., Gerlinger, G., Heinz, A., et al. (2021) · Der Nervenarzt

Psychiatric care and mental health servicesCOVID-19 and Mental Health

Cited by 36

Reconceptualising treatment‐resistant depression as difficult‐to‐treat depression

McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2021) · The Lancet Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 30